The new Food and Drug Administration ban on most flavored e-cigarettes contains a loophole that allows teens to use disposable devices, The New York Times reports.
The Food and Drug Administration did not ensure that a program designed to reduce improper opioid prescribing was effective, according to a report published this week.
The Food and Drug Administration has issued a warning to consumers to stop using vaping products containing THC, the psychoactive ingredient in marijuana.
The Food and Drug Administration announced this week it has received 127 reports of seizures or other neurological symptoms that may be related to e-cigarettes, according to CNN.
The Food and Drug Administration this week warned two companies selling the herbal supplement kratom not to market their products as a treatment for opioid addiction, USA Today reports.
The Food and Drug Administration said this week it has become aware of reports that some people who use e-cigarettes, especially youth and young adults, are experiencing seizures following their use.
The Food and Drug Administration has issued a policy designed to reduce underage vaping by restricting how and where flavored e-cigarettes are sold, The Washington Post reports.
U.S. Food and Drug Administration Commissioner Scott Gottlieb, who has won bipartisan support for his efforts to reduce minors’ use of flavored e-cigarettes, announced this week he will leave the agency next month.
The U.S. Food and Drug Administration announced this week it will take new steps to address the nation’s opioid epidemic, according to The Wall Street Journal.
The U.S. Food and Drug Administration is weighing whether to recommend prescribing the opioid overdose antidote naloxone along with opioid prescriptions, CNN reports.
A new study concludes the U.S. Food and Drug Administration and drug manufacturers allowed the widespread prescribing of a fentanyl painkiller to ineligible patients.
The U.S. Food and Drug Administration (FDA) has issued a new round of warnings and advisory letters to makers of dietary supplements, telling them not to falsely claim their products cure, prevent or treat serious diseases. Last year the FDA and the Federal Trade Commission sent warning letters to makers and distributors of 12 products sold as treatments for opioid addiction and withdrawal.
The U.S. Food and Drug Administration has taken a step to make it easier for companies that make the opioid overdose antidote naloxone to sell the drug without a prescription, CNBC reports.
A new opioid, Dsuvia, that is far more potent than fentanyl and 500 times stronger than morphine is nearing approval by the U.S. Food and Drug Administration, according to MarketWatch.
The Food and Drug Administration seized more than a thousand documents from e-cigarette maker Juul Labs last week in a surprise inspection, according to The New York Times. The agency said the documents were related to Juul’s sales and marketing practices.
Youth e-cigarette use in the United States is an epidemic, Food and Drug Administration Commissioner Scott Gottlieb said Wednesday. He announced new steps the agency is taking to prevent youth vaping.
The Food and Drug Administration did not act to stop off-label prescribing for fast-acting fentanyl drugs, putting patients at high risk of accidental overdose and death, The New York Times reports.
The Food and Drug Administration issued new scientific recommendations this week designed to encourage development of new medication-assisted treatment drugs for opioid use disorder.
Some doctors looking for alternatives to opioids to treat back pain are using an injectable drug that carries risks of injury and complications, according to The New York Times.
This website uses cookies. We use cookies and similar technologies to give
you the best experience. By using this website, you accept our Privacy Policy and Terms of Use.
Get Support
